Inhibition of ATR-dependent signaling by protoapigenone and its derivative sensitizes cancer cells to interstrand cross-link–generating agents in vitro and in vivo

Wang, Hui-Chun, Lee, Alan Yueh-Luen, Chou, Wen-Cheng, Wu, Chin-Chung, Tseng, Chao-Neng, Liu, Kevin Yen-Ting, Lin, Wen-Lien, Chang, Fang-Rong, Chuang, Da-Wei, Hunyadi, Attila, Wu, Yang-Chang: Inhibition of ATR-dependent signaling by protoapigenone and its derivative sensitizes cancer cells to interstrand cross-link–generating agents in vitro and in vivo.
Molecular Cancer Therapeutics, 11 (7). pp. 1443-1453. ISSN 1535-7163 (2012)

This is the latest version of this item.

[img]
Preview
Text
2047292 Wang et al Mol Cancer Ther_2012.pdf - Published Version

Download (2MB) | Preview
Item Type: Article
Journal or Publication Title: Molecular Cancer Therapeutics
Date: 2012
Volume: 11
Number: 7
Page Range: pp. 1443-1453
ISSN: 1535-7163
Publisher: American Association for Cancer Research
Faculty: Faculty of Pharmacy
Department: Farmakognóziai Intézet
Institution: Szegedi Tudományegyetem
MTMT id: 2047292
DOI id: https://doi.org/10.1158/1535-7163.MCT-11-0921
Date Deposited: 2013. May. 31. 11:28
Last Modified: 2018. Jul. 13. 08:40
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/3104

Available Versions of this Item

  • Inhibition of ATR-dependent signaling by protoapigenone and its derivative sensitizes cancer cells to interstrand cross-link–generating agents in vitro and in vivo. (2013. May. 31. 11:28) [Currently Displayed]

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year